Haemonetics Corporation
103.16USD
+0.3200 (+0.31%)
Consensus EPS on the street’s adjusted basis, not the filed GAAP figure — which is why the actuals here can differ from the income statement.
| Period | Consensus EPS | 90 days ago | Revisions up (30d) | Revisions down (30d) |
|---|---|---|---|---|
| Current quarter | $1.29▲ | $1.28 | 6 | 3 |
| Next quarter | $1.35▼ | $1.38 | 3 | 5 |
| Current year | $5.3▲ | $5.22 | 11 | 0 |
| Next year | $5.74▼ | $5.77 | 3 | 6 |
Beat in 4 of the last 4
| Quarter | Estimate | Actual | Surprise |
|---|---|---|---|
| 2026-06-30 | $1.08 | $1.14 | +0.06 (+5.8%) |
| 2026-03-31 | $1.27 | $1.29 | +0.02 (+1.4%) |
| 2025-12-31 | $1.25 | $1.31 | +0.06 (+4.8%) |
| 2025-09-30 | $1.11 | $1.27 | +0.16 (+14.3%) |
182 ratings from 21 firms
Ratings are attributed to the research firm, not to individual analysts. See every ticker.
| Firm | Action | Rating | Price Target | Date |
|---|---|---|---|---|
| Raymond James | Maintained | Outperform | $105 $125 | Sep 3, 2026 |
| Baird | Maintained | Outperform | $96 $119 | Aug 21, 2026 |
| Barrington Research | Maintained | Outperform | $95 $118 | Aug 19, 2026 |
| BTIG | Maintained | Buy | $96 $110 | Aug 18, 2026 |
| Citigroup | Maintained | Neutral | $79 $92 | Aug 7, 2026 |
| JP Morgan | Maintained | Neutral | $62 $86 | Aug 7, 2026 |
| BTIG | Maintained | Buy | $84 $96 | Aug 6, 2026 |
| Mizuho | Maintained | Outperform | $85 $90 | Jul 15, 2026 |
| BTIG | Reiterated | Buy | $84 | Jun 26, 2026 |
| BTIG | Reiterated | Buy | $84 | Jun 17, 2026 |
| Mizuho | Maintained | Outperform | $70 $85 | Jun 15, 2026 |
| Citigroup | Maintained | Neutral | $64 $70 | May 28, 2026 |
| B of A Securities | Upgraded from Neutral | Buy | $72 $80 | May 22, 2026 |
| Barrington Research | Maintained | Outperform | $94 $89 | May 12, 2026 |
| JP Morgan | Maintained | Neutral | $74 $62 | May 8, 2026 |
| Mizuho | Maintained | Outperform | $80 $70 | Apr 13, 2026 |
| Citigroup | Maintained | Neutral | $70 $64 | Apr 7, 2026 |
| Citigroup | Maintained | Neutral | $75 $70 | Mar 11, 2026 |
| Citigroup | Maintained | Neutral | $88 $75 | Feb 6, 2026 |
| Mizuho | Maintained | Outperform | $90 $80 | Feb 6, 2026 |
| Barrington Research | Maintained | Outperform | $93 $94 | Feb 6, 2026 |
| BTIG | Reiterated | Buy | $88 | Feb 6, 2026 |
| Barrington Research | Maintained | Outperform | $93 | Feb 2, 2026 |
| Barrington Research | Maintained | Outperform | $90 $93 | Jan 12, 2026 |
| BTIG | Reiterated | Buy | $88 | Jan 9, 2026 |
37 filings from 15 insiders · 0 buy / 0 sell over 6m
Officers and directors of HAE, from the last two years of filings. Grants, gifts and option exercises are shown but not colour-coded — they are compensation, not a view on the price.
| Insider | Action | Shares | Price | Value | Date |
|---|---|---|---|---|---|
| KROLL MARK WDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| ABERNATHY ROBERT EDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| COYLE MICHAEL JDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| ZANE ELLEN MDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| MADAUS MARTIN D PH.D.Director | Grant | 2.5k | — | — | Jul 24, 2026 |
| POMEROY CLAIREDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| BRYANT DIANE MDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| JOHNSON LLOYD EMERSONDirector | Grant | 2.5k | — | — | Jul 24, 2026 |
| DARECCA JAMESChief Financial Officer | Grant | 29.3k | — | — | May 15, 2026 |
| MILLER LAURIE AOfficer | Grant | 13.3k | — | — | May 15, 2026 |
| GALVIN ROYOfficer | Grant | 27.5k | — | — | May 15, 2026 |
| MAUNSELL FARRIS MARYANNEOfficer | Grant | 2.2k | — | — | May 15, 2026 |
| SIMON CHRISTOPHERChief Executive Officer | Grant | 78.3k | — | — | May 15, 2026 |
| BASIL MICHELLE LGeneral Counsel | Grant | 28.4k | — | — | May 15, 2026 |
| KROLL MARK WDirector | Buy | 1.4k | $70.56 | $99k | Nov 10, 2025 |
| KROLL MARK WDirector | Grant | 2.7k | — | — | Jul 24, 2025 |
| ABERNATHY ROBERT EDirector | Grant | 2.7k | — | — | Jul 24, 2025 |
| COYLE MICHAEL JDirector | Grant | 2.7k | — | — | Jul 24, 2025 |
| ZANE ELLEN MDirector | Grant | 2.7k | — | — | Jul 24, 2025 |
| DOCKENDORFF CHARLES JDirector | Grant | 2.7k | — | — | Jul 24, 2025 |
No analyst notes on HAE yet.
Analyst Ratings
10 analysts covering
| Period | Strong Buy | Buy | Hold | Sell | Strong Sell | Consensus |
|---|---|---|---|---|---|---|
| Current | 4 | 4 | 3 | 0 | 0 | Buy1.91 |
| 1 mo ago | 4 | 4 | 3 | 0 | 0 | Buy1.91 |
| 2 mo ago | 4 | 4 | 3 | 0 | 0 | Buy1.91 |
| 3 mo ago | 4 | 4 | 3 | 0 | 0 | Buy1.91 |